SCHEMBL16056811

SCHEMBL16056811

Cc1c(-c2ccc(C(=O)N3CCCCC3)cc2)ccn(C(=O)O)c1=O

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 9/20 0.50
▸ ALDH1A1 P00352 4/20 0.50
▸ MAPK1 P28482 1/20 0.50
▸ BRD4 O60885 1/20 0.46
▸ MAPK14 Q16539 1/20 0.45
▸ TSHR P16473 3/20 0.44
▸ NPC1 O15118 2/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ PARP1 P09874 1/20 0.44
▸ PKM P14618 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ USP2 O75604 1/20 0.43
▸ KDM1A O60341 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ BRD9 Q9H8M2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16057266 0.88 TAF1 (0.49) HPGDALDH1A1BRD4TSHRKMT2A
SCHEMBL14975270 0.77 KDM4E (0.39) ALDH1A1MAPK1BRD4KMT2AMEN1
SCHEMBL16057572 0.76 NPC1 (0.53) HPGDALDH1A1MAPK1MAPK14TSHR
SCHEMBL16057309 0.71 MCL1 (0.40) ALDH1A1NPC1RAB9AKMT2AMEN1
SCHEMBL27479149 0.71 HPGD (1.00) HPGDALDH1A1MAPK1TSHRKMT2A
SCHEMBL7132525 0.71 HPGD (1.00) HPGDALDH1A1MAPK1TSHRKMT2A
SCHEMBL3456729 0.70 HPGD (0.96) HPGDALDH1A1MAPK1TSHRNPC1
SCHEMBL3454812 0.70 HPGD (0.96) HPGDALDH1A1MAPK1TSHRNPC1
SCHEMBL16058501 0.70 EGFR (0.52) HPGDALDH1A1MAPK1MAPK14TSHR
SCHEMBL20460439 0.70 HPGD (0.80) HPGDALDH1A1TSHRNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9828338-B2 Carbamate derivatives of lactam based N-acylethanolamine acid amidase (NAAA) inhibitors THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-11-28 — — US disclosed
US-20160068482-A1 CARBAMATE DERIVATIVES OF LACTAM BASED N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) INHIBITORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2016-03-10 — — US disclosed
WO-2014144836-A2 CARBAMATE DERIVATIVES OF LACTAM BASED N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) INHIBITORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-09-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160068482-A1 CARBAMATE DERIVATIVES OF LACTAM BASED N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) INHIBITORS NAAA, FAAH, FAAH2 HPGD 772/4885ALDH1A1 1195/4885MAPK1 3901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback